Research and Development
FDA approves Gilead’s latest HIV treatment
April 5, 2016 Manufacturing and Production, Research and Development Gilead, HIV, descovy, taf, taf-based, therapy
Gilead to buy Nimbus Therapeutics’ unit, trial drug for up to $1.2 billion
April 5, 2016 Manufacturing and Production, Research and Development, Sales and Marketing Gilead Sciences, M&A, MA, Nimbus Apollo, Nimbus Therapeutics, merger and acquisitions
Janssen and Genmab sued for patent infringement in US
April 5, 2016 Manufacturing and Production, Research and Development, Sales and Marketing Genmab, Janssen, darzalex, morphosys, patent infringement
Eisai’s Halaven recommended for European approval
April 4, 2016 Research and Development, Sales and Marketing Eisai, Halaven, liposarcoma
Weekly Movers: Lupin, Natco Pharma, Keryx, Puma Biotech
April 4, 2016 Research and Development, Sales and Marketing
Research shows Novartis’s Entresto reduces cardiovascular death and heart failure
April 4, 2016 Research and Development, Sales and Marketing Entresto, Novartis, Regeneron, Sanofi, cardiovascular, clinical trial, patent
Amicus Therapeutics’ Fabry disease drug gets European regulatory support
April 4, 2016 Research and Development, Sales and Marketing Amicus Therapeutics, EMA, Fabry disease, genetic disorder, rare disease
Novo says Victoza bests MSD’s Januvia at lowering blood sugar
April 4, 2016 Research and Development Novo Nordisk, Victoza
Amgen’s high cholesterol drug at centre of patent court case yields positive clinical trial results
April 4, 2016 Research and Development, Sales and Marketing Amgen, Repatha, Sanofi, high cholesterol. ldl, ldl-c, phase III, statins
GSK’s gene therapy for rare condition in children gets EMA backing
April 4, 2016 Research and Development, Sales and Marketing ADA-SCID, European Medicines Agency, GlaxoSmithKline, Orphan Therapy, Rare Treatment, drug trial, gene therapy
Timeline of turmoil – Valeant Pharmaceuticals’ troubled March 2016
April 4, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Share price, Valeant, fall, month from hell, timeline, turmoil
Two CHMP nods for Janssen
April 4, 2016 Research and Development, Sales and Marketing Xeplion, darzalex, multiple myeloma
Pfizer’s cholesterol-lowering bococizumab shows promise in Phase III trials
April 1, 2016 Research and Development, Sales and Marketing Pfizer, bococizumab, lipid, phase 3, phase III, spire, spire-ai
FDA to review investigational hepatitis B vaccine
April 1, 2016 Medical Communications, Research and Development dynavax, hepatitis B, vaccines
Janssen to stop fulranumab development in osteoarthritis pain
April 1, 2016 Medical Communications, Research and Development, Sales and Marketing Amgen, Janssen
